3,720
Participants
Start Date
November 21, 2023
Primary Completion Date
October 31, 2028
Study Completion Date
December 31, 2028
Amoxicillin/Clavulanate Potassium 875 MG-125 MG Oral Tablet
Amoxicillin/clavulanate, oral, 875mg/125mg twice daily for 7 days
Placebo
Placebo for amoxicillin/clavulanate, oral, twice daily for 7 days
Budesonide nasal spray
Budesonide nasal spray, 32 mcg per spray, 2 sprays per nostril, once per day
C-reactive protein
Measurement of C-reactive protein level in capillary blood
RECRUITING
Penn State College of Medicine, Hershey
RECRUITING
Georgetown University Medical Center, Washington D.C.
NOT_YET_RECRUITING
MedStar Health Research Institute, Hyattsville
RECRUITING
Virginia Commonwealth University, Richmond
RECRUITING
University of Wisconsin-Madison, Madison
RECRUITING
University of California, Los Angeles, Los Angeles
RECRUITING
University of Washington, Seattle
Collaborators (1)
Patient-Centered Outcomes Research Institute
OTHER
Medstar Health Research Institute
OTHER
Penn State College of Medicine
UNKNOWN
University of Washington
OTHER
Virginia Commonwealth University
OTHER
University of California, Los Angeles
OTHER
University of Wisconsin, Madison
OTHER
Daniel Merenstein
OTHER